From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs.

Giardina SF, Culver A, Ahmed C, Mirescu C, Oblak AL, Brosch J, Clayton WB, Dage JL, Lamb BT, Richardson TI, Small D, Palkowitz AD.

Open source

DOI
10.1002/alz.71165
Published
2026-02-01
Container
Alzheimers Dement
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/alz.71165,
  title = {From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs.},
  author = {Giardina SF and  Culver A and  Ahmed C and  Mirescu C and  Oblak AL and  Brosch J and  Clayton WB and  Dage JL and  Lamb BT and  Richardson TI and  Small D and  Palkowitz AD.},
  year = {2026},
  journal = {Alzheimers Dement},
  doi = {10.1002/alz.71165},
  url = {https://doi.org/10.1002/alz.71165}
}

RIS

TY  - JOUR
TI  - From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs.
AU  - Giardina SF
AU  -  Culver A
AU  -  Ahmed C
AU  -  Mirescu C
AU  -  Oblak AL
AU  -  Brosch J
AU  -  Clayton WB
AU  -  Dage JL
AU  -  Lamb BT
AU  -  Richardson TI
AU  -  Small D
AU  -  Palkowitz AD.
PY  - 2026
JO  - Alzheimers Dement
DO  - 10.1002/alz.71165
UR  - https://doi.org/10.1002/alz.71165
ER  - 

APA

SF, G., A, C., C, A., C, M., AL, O., J, B., WB, C., JL, D., BT, L., TI, R., D, S., & AD., P. (2026). From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs.. Alzheimers Dement. https://doi.org/10.1002/alz.71165

Source records